PhytoDental Solutions announces addition of Garth D. Ehrlich, Ph.D., FAAAS, FAAM to its Science, Data and Health Advisory Board.

| Press Releases

PhytoDental Solutions announces addition of Garth D. Ehrlich, Ph.D., FAAAS, FAAM to its Science, Data and Health Advisory Board.

Dr Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCOM) in Philadelphia, PA, USA. Dr. Ehrlich is also the founder and director of three Research Centers of Excellence in the Institute for Molecular Medicine and Infectious Disease: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing (CAMP); and the Center for Surgical Infections and Biofilms. He also directs Drexel University’s Core Genomics Facility, which is a University-wide sequencing and bioinformatics service core, and the Meta-Omics Shared Resource for the Sidney Kimmel Cancer Center – an NCI-designated Cancer Center.

Dr. Ehrlich is editor-in-chief of Genetic Testing and Molecular Biomarker, a MaryAnn Liebert Publication, and an associate editor of BMC Evolutionary Biology and the MDPI journal GENES. He has a Google h-factor of 75 with nearly 24,000 citations of his published papers and a ResearchGate h-factor of 70 with an RG Score of 51, and has had six papers cited by the Faculty of 1000.

Dr. Ehrlich and his lab have used large-scale comparative genomic technologies to explore the molecular pathogenesis of chronic infectious diseases and the human genetics of susceptibility and resistance to infection, particularly to understand how chronic bacterial pathogens persist in the face of antimicrobial therapy, and the innate and adaptive host responses.

About PhytoDental Solutions

PhytoDental Solutions (“PDS”) is dedicated to developing phytocannabinoid-based and augmented formulations for applications across the spectrum of dental diseases and surgical procedures, to provide patients with products of special effect for daily oral care, and at the same time, introducing advanced technology to build a system of precision dentistry to systematically solve the long-standing pain points in the dental and health management industries.

PDS provides a series of professional and consumer products including clinically and statistically validated indication specific formulation products for dental anxiety, denture stomatitis, orthodontic caries and gingivitis, periodontitis, peri-implantitis, pre-, post- dental surgical care, and anti-inflammatory consumer products including toothpaste, dental floss, mouthwash and a series of dental appliances for home use.

PDS indication special formulations are capable of forming a powerful supplement or even replacement for the obvious clinical defects of most products in the dental market.

By promoting the precise application of cannabinoids in dentistry to block the common "oral entrance of pathogens", the systemic health of patients is improved, and an innovative new model of health management - "Dental Health is Well Health" created.

Shopping Cart